The Diagnosis of Lupus

Similar documents
LUPUS. and Associated Conditions LUPUSUK 2015

LUPUS. and Associated Conditions LUPUSUK 2018

Lupus. and the Kidneys

Lupus. Fast facts. What is lupus? What causes lupus? Who gets lupus?

LUPUS. and Medication LUPUSUK 2015

LUPUS. The Mouth, Nose and Eyes LUPUSUK 2018

LUPUS. The Skin and Hair LUPUSUK 2015

and the Brain Published by Reg. Charity Nos , SC LUPUS UK.

Definition Chronic autoimmune disease The body s immune system starts attacking itself Can affect most organs and tissues in the body Brain, lungs, he

Arthritis & Rheumatology Clinics of Kansas PATIENT EDUCATION SYSTEMIC LUPUS ERYTHEMATOSUS

UNDERSTANDING SYSTEMIC LUPUS ERYTHEMATOSUS

AUTOIMMUNE DISORDERS IN THE ACUTE SETTING

High Impact Rheumatology

2/23/18. Disclosures. Rheumatic Diseases of Childhood. Making Room for Rheumatology. I have nothing to disclose. James J.

Learning about Lupus. Learning About Lupus. Lupus Society of Illinois

Summary Article: Lupus (Systemic Lupus Erythematosus) from Harvard Medical School Health Topics A-Z

9/25/2013 SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)

Living with Lupus: An Insider s Perspective

Drug information. Sarilumab SARILUMAB. is used to treat rheumatoid arthritis. Helpline

10/25/2018. Autoimmunity and how to treat it. Disclosure. Why do we get autoimmunity? James Verbsky MD/PhD Pediatric Rheumatology/Immunology

Hydroxychloroquine. Drug information Hydroxychloroquine

Subacute cutaneous lupus erythematosus

Systemic Lupus Erythematosus

LUPUS CAN DO EVERYTHING, BUT NOT EVERYTHING IS LUPUS LUPUS 101 SLE SUBSETS AUTOIMMUNE DISEASE 11/4/2013 HOWARD HAUPTMAN, MD IDIOPATHIC DISCOID LUPUS

Leflunomide Treatment Rheumatology Patient Information Leaflet

Azathioprine. Drug information. Azathioprine is used to treat rheumatoid arthritis, lupus and other conditions.

NATIONAL LABORATORY HANDBOOK. Laboratory Testing for Antinuclear antibodies

Autoimmune Liver Disease

Systemic Lupus Erythematosus Defining Lupus

Tocilizumab Tocilizumab

ONE of the following:

LUPUS (SLE) MEDICAL SOURCE STATEMENT

Treating kidney diseases with rituximab. Information for patients

Your child s prednisolone. This leaflet is for parents of children taking prednisolone to treat their inflammatory condition.

The Leeds Teaching Hospitals NHS Trust Juvenile Idiopathic Arthritis (JIA)

High dose melphalan conditioning for autologous transplant (inpatient) Palatine treatment centre

Rheumatology 101 A Pediatrician s Guide

.,Dr Ali Alkazzaz Babylon collage of medicine 2016

Residual Functional Capacity Questionnaire SYSTEMIC LUPUS ERYTHEMATOSUS

Drug information. Baricitinib BARICITINIB. is used to treat rheumatoid arthritis. Helpline

MANAGING THE PATIENT WITH POSITIVE ANA

. Autoimmune disease. Dr. Baha,Hamdi.AL-Amiedi Ph.D.Microbiology

What will we discuss today?

LUPUS AND LUPUS KIDNEY DISEASE

Jonnie. By Frankie Liang. (Autobiographical Narrative)

Pain or stiffness in joints after periods of inactivity or excessive use

Information on Azathioprine for Inflammatory Bowel Disease

Past Medical History. Chief Complaint: Appointment Date: Page 1

Ciclosporin. Drug information. Ciclosporin is used to treat rheumatoid arthritis, lupus, psoriatic arthritis and other conditions.

The information you provide us will greatly help us provide the highest quality and most comprehensive care for you.

The Power of the ANA. April 2018 Emily Littlejohn, DO MPH

Autoimmune diseases. SLIDE 3: Introduction to autoimmune diseases Chronic

Raynaud's Phenomenon. Information for patients Sheffield Vascular Institute

Editing file. Color code: Important in red Extra in blue. Autoimmune Diseases

Important safety information to minimise the risk of immune-related adverse reactions

To live with lupus, we need to know about lupus.

Cutaneous manifestations and systemic correlation in patients with lupus erythematosus and its subsets: a study of 40 cases

Undifferentiated Connective Tissue Disease and Overlap Syndromes. Mark S. Box, MD

Gemcitabine and Cisplatin (urology)

JUST FOR KIDS SELECTED IMPORTANT SAFETY INFORMATION

Benlysta (belimumab) Prior Authorization Criteria Program Summary

Nivolumab. Nivolumab

OU Children s Physicians Pediatric Arthritis Center

NORTH AND EAST DEVON HEALTHCARE COMMUNITY SHARED CARE PRESCRIBING GUIDELINE

Dr. Venkateswari. R. Dr. Janani Sankar s unit Kanchi Kamakoti CHILDS Trust Hospital

Athens Rheumatology Clinic, LLC Sana Makhdumi, MD

Development of SLE among Possible SLE Patients Seen in Consultation: Long-Term Follow-Up. Disclosures. Background. Evidence-Based Medicine.

Methotrexate Methotrexate.indd 1 9/1/16 11:40 AM

PATIENT MEDICAL HISTORY PATIENT INFORMATION

1231 Zoledronic acid in early breast cancer Page 1 of 5

RHEUMATOLOGY PATIENT HISTORY FORM

ILLINOIS BONE AND JOINT INSTITUTE Rheumatology Medical History Form

Systemic Lupus Erythematosus among Jordanians: A Single Rheumatology Unit Experience

Ask the Expert: Photosensitivity in Cutaneous Lupus

When IT All Goes Wrong and Your Immune System Attacks Its Own Body

How Is Lupus Diagnosed?

Rheumatoid Arthritis

Who is this leaflet for? What is hyperthyroidism? What is the thyroid gland? What causes hyperthyroidism? How is hyperthyroidism diagnosed?

Methotrexate. You will have a routine blood test before the start of each cycle of treatment.

Drug information. Belimumab BELIMUMAB. is used to treat lupus (SLE) Helpline

Northumbria Healthcare NHS Foundation Trust. Bronchiectasis. Issued by Respiratory Medicine

Policy. Section: Medicine Effective Date: January 15, 2015 Subsection: Pathology/Laboratory Original Policy Date: December 5, 2014 Subject:

YOUR GUIDE TO TECENTRIQ (atezolizumab) non-small cell lung cancer (NSCLC)

Looking after your lungs

Myeloma Haematology and Transplant Unit

Gemcitabine and carboplatin (Breast)

Preparing for Your Immune Checkpoint Inhibitor (CPI) Treatment

Familial Mediterranean Fever

SLE-key Case Studies

Protecting your baby against meningitis and septicaemia

Insights into the DX of Pediatric SLE

ALL Consolidation (cycles 1-4)

Sorafenib (Nexavar ) For thyroid carcinoma

Rheumatology Department Patient Information Leaflet

9/13/2015. Nothing to disclose

Palindromic rheumatism

Why have I been selected for treatment with adalimumab?

Please be sure to check with your insurance company to make sure that Dr. Kohli is covered under your plan.

DISCUSSION BY: Dr M. R. Shakeebi, MD, Rheumatologist

Large granular lymphocytic leukaemia (LGLL)

Transcription:

The Diagnosis of Lupus LUPUSUK 2017

This information booklet has been produced by LUPUS UK 2017 LUPUS UK LUPUS UK is the registered national charity for people with systemic lupus erythematosus (SLE) and discoid lupus erythematosus (DLE) supporting our members through the Regional Groups and advising others as they develop the symptoms prior to diagnosis You can help by taking up membership. For more information contact LUPUS UK, St James House, Eastern Road, Romford, Essex RM1 3NH Tel: 01708 731251 www.lupusuk.org.uk Reg. Charity No: 1051610, SC039682 LUPUS UK is certified under the requirements of the Information Standard. Please contact National Office should you require further information on the sources used in the production of this booklet or for further information about lupus. LUPUS UK will be pleased to provide a booklist and details of membership.

DIAGNOSIS OF LUPUS Introduction: Systemic lupus erythematosus (SLE) can be difficult to diagnose as it has similar symptoms to several other, more common, diseases. This booklet has been produced as a guide for those seeking a diagnosis to provide more information about the process and tests involved. Lupus is an autoimmune disease whereby the person s immune system gets confused and attacks their own cells and tissues rather than only targeting matter foreign to the body (such as bacteria and viruses). Symptoms depend on which organs lupus may be affecting. However, common symptoms tend to be fatigue, joint pain, loss of appetite, skin rash, weight loss, fevers and hair loss. Fatigue in particular can be persistent and disabling for many. Lupus can affect different people in many different ways. It can also range from being mild to potentially serious if many organ systems are affected. It is important to make the diagnosis of lupus early so that treatment may commence in a timely manner. However, physicians are also cautious in labeling someone with lupus when they do not have this condition, therefore a thorough clinical assessment and numerous tests are often needed to confidently make the diagnosis. The ultimate goal of treatment is to both control current lupus activity and also prevent lupus from causing irreversible damage to organs, thus allowing the patient to maintain as normal a life as possible both in the present and future. In order for this to occur a confident diagnosis of lupus needs to be made and ideally needs to be made early. This information booklet summarises how a physician arrives at a diagnosis of lupus in order for treatment to be started. John Ioannou PhD FRCP Reader and Honorary Consultant in Adolescent and Adult Rheumatology Principal Investigator - Arthritis Research UK Centre for Adolescent Rheumatology University College London, University College London Hospital, Great Ormond Street Hospital 1

DIAGNOSIS OF LUPUS Lupus is the short-hand term used when referring to Systemic Lupus Erythematosus or SLE. The word systemic means that the disease can affect different parts of the body. In fact lupus (SLE) can potentially affect any organ of the body. Commonly it may affect the skin, joints, kidneys, membranes lining the lungs or heart, blood cells, lungs and nervous system Principles in making a diagnosis In order for a physician to reach a diagnosis of lupus three essential steps are required: 1) A detailed overview of the patients symptoms and past medical history 2) A detailed physical examination, which includes testing the urine 3) Tests - mostly blood tests but this may also involve other tests such as biopsy of the affected organs e.g. kidney or skin SLE can often mimic other conditions. For example, if a patient has a fever associated with lupus, physicians will want to ensure this is not due to an infection. It is often necessary to undertake tests to rule out other conditions before a diagnosis of lupus can be made with confidence. Specific diagnostic features of lupus The American College of Rheumatology established 11 abnormalities or criteria which, if combined, strongly suggests that the patient has lupus. These are termed classification criteria which are necessary in research studies to ensure that patients enrolled into the studies have lupus. Of the 11 criteria listed in table 1, a patient needs to have four or more to be classified as having lupus. The criteria were developed in 1982 and revised in 1997. They have stood the test of time and have proven to be very good at identifying patients with lupus. Many physicians effectively use these as diagnostic criteria. CRITERIA MALAR RASH DISCOID RASH PHOTOSENSITIVITY ORAL ULCERS SEROSITIS DESCRIPTION Rash over the cheeks Red, sometimes circular, patches of skin with scaling Skin very sensitive to sunlight Recurrent crops of ulcers within the mouth or nose Inflammation of the membranes that line the lungs or heart 2

ARTHRITIS Affecting two or more joints - causing stiffness and pain RENAL Inflammation of the filtering apparatus in the kidneys called the glomerulus, which leads to protein leaking out into the urine NEUROLOGICAL Can affect the nerves in many different ways, such as siezures or psychosis HAEMATOLOGICAL Low levels of haemglobin (anaemia), white cells (which help fight infection) and/or platelets (which help in blood clotting) IMMUNOLOGICAL-1 Antibodies to double-stranded DNA, Sm and/or phospholipid (e.g. anti-beta2 glycoprotein I or lupus anticoagulant) IMMUNOLOGICAL-2 Anti-nuclear antibodies (ANA) Table 1 - Adaptation of the American College of Rheumatology classification criteria for SLE Sometimes a tissue biopsy is helpful to both confirm the diagnosis and define the severity of inflammation that might be occurring in that organ. This is most frequently performed when lupus affects the skin or kidneys. It is important to mention that some people develop these features shown in table1 sequentially or gradually. Hence, some people may be termed as having evolving lupus or a lupus-like condition. Another term that is often used is undifferentiated autoimmune rheumatic disease. In these patients, whilst a diagnosis of lupus is not definite, often a period of monitoring is necessary to establish whether lupus evolves or not. It is often necessary to start treatment even when a definite diagnosis of lupus cannot be made. There is also a huge range in severity when patients are diagnosed - some have relatively mild disease (for example, a mild malar rash, mouth ulcers and positive ANA and double-stranded DNA antibodies with no major organ involvement) whilst, at the other end of the spectrum, patients may present with severe disease with major organ involvement at the outset, (for example, psychosis and kidney involvement). Making the diagnosis can sometimes be more difficult and/or delayed in either those with milder disease or those with more gradual onset of symptoms, making awareness of lupus all the more important amongst health care professionals and the public. Why and how are the immunological tests important in helping to make the diagnosis? Anti-double stranded DNA antibodies are very specific for lupus in that they are typically not seen in any other condition nor in the healthy population. However, they are not very sensitive in picking up lupus, occurring in around 60% of 3

patients with lupus. If someone is positive for these antibodies, it often means they have lupus, but if they are negative it does not necessarily mean they do not have lupus. Conversely, ANA is very sensitive for lupus as over 95% of everyone with lupus has these antibodies. However, they are also present in many other conditions, such as rheumatoid arthritis, and even around 10% of the healthy population test positive for this - they are not specific for SLE. If someone tests positive for ANA it does not necessarily mean that they have lupus, however, if they are negative then it very unlikely that they have lupus. Both ANA and anti-dsdna antibody tests are helpful in providing an indicator as to whether the patient s symptoms may be due to lupus. There are also other antibodies which may be helpful, like anti-sm antibodies which are also very specific for lupus but even less sensitive, occurring in only around 10% of people with lupus. Also testing for a protein called complement-3 (C3), that is not an antibody but still involved in the immune system, may be helpful as low levels of C3 suggests lupus. Is the diagnosis of lupus made in the same way for younger people? Around 15-20% of everyone with lupus develops lupus as a child (defined as under the age of 17 or 18 years). When this occurs, the diagnosis is childhood onset or juvenile onset SLE (JSLE). Though the age of onset is younger, the classification criteria used for adult SLE as shown in table1 are also the same for JSLE. Therefore, the diagnosis in young people is made effectively in the same way as that for adults. General non-specific symptoms Many people with lupus have symptoms that do not feature in the classification criteria but which nevertheless are severe in that they adversely affect their quality of life. These include: 1) fatigue - which can be severe and unremitting 2) joint and/or muscle aches 3) hair loss 4) Raynauds (when the fingers and sometimes toes can drain in colour and go white, or become blue, often in response to the cold. They may also become painfully red in the warmth) 5) loss of appetite 6) weight loss 7) fevers 8) night sweats 9) low mood, anxiety 10) swollen glands 4

These symptoms are common in many patients with lupus, but they are not included in the classification criteria as many other diseases can cause these symptoms. For example, bad flu can cause fever, fatigue, joint and muscle ache, swollen glands and loss of appetite. In fact, many patients liken having lupus to having very bad flu all the time. It is when these symptoms are persistent that physicians should at least consider lupus amongst other potential causes as the diagnosis. Six helpful hints in diagnosing lupus and predicting flares: 1) Recurrent mouth ulcers are common, especially in teenagers, but this does not necessarily mean someone has lupus. However, if mouth ulcers are also accompanied by other symptoms such as a skin rash made worse by sun exposure, joint pain and stiffness and extreme fatigue, then it is worth investigating for the possibility of lupus. 2) In young people onset of lupus can mimic a number of other diseases. For example, teenagers in early lupus disease are misdiagnosed as having a viral infection such as glandular fever or prolonged flu. Often lupus is not considered by the GP, especially in children and adolescents. 3) Fatigue and hair loss may be due to lupus but there are also many other causes which often occur more frequently in patients with lupus. Examples include; an underactive thyroid gland, anaemia, iron deficiency and possibly vitamin D deficiency. It is important that the treating physician does not just assume fatigue and / or hair loss is due to lupus and looks for other reversible causes. 4) Typically in lupus, blood tests may show a raised ESR with normal CRP, however, if the CRP is also very high then this implies that something else is going on, usually an infection. 5) Lymphocyte counts are often low in lupus, especially if the disease is active. Usually one does not reduce treatment of lupus if lymphocytes alone are low. 6) Experience from running a large adolescent and young adult lupus clinic indicates that stress can associate with flares of lupus. Managing stress is important. Infections can also precipitate flares of lupus. It is important that prescribed medicines are taken according to instructions and that, should a flare occur, the patient seeks help from the GP or hospital physician. Information on medication used in the treatment of lupus can be found in the factsheet LUPUS and Medication available from LUPUS UK. 5

Your Notes 6

Your Notes 7

LUPUS UK LUPUS UK is a registered charity with more than 5,000 patient members supported by the Regional Groups. We provide a large variety of information for those seeking a better understanding of lupus. The charity offers a comprehensive range of books for purchase and can supply free of charge Information Packs for individuals, nurses and GPs. The LUPUS UK national magazine LUPUS UK News & Views is published three times during the year with particular emphasis on medical articles concerning lupus. Publicity materials, leaflets, posters, a dvd for the newly diagnosed, media releases and more are always available from the charity s National Office for better awareness about lupus in clinics, hospitals and public places. 5k RW 03/17 Last reviewed 02/17 Next Review due 02/20 LUPUSUK 2017